Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Mareike Frick, Fazila Asmar, Viktor Ljungström, Markus Schneider, Kenichi Yoshida, Aron Skaftason, Tatjana Pandzic, Blanca Gonzalez, Anna Tasidou, Nils Waldhueter, Alfredo Rivas-Delgado, Maria Angelopoulou, Marita Ziepert, Christopher Maximilian Arends, Lucile Couronné, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga D. Munch-Petersen, Thorsten Zenz, Martin-Leo Hansmann, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Martin Erlanson, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Seishi Ogawa, Ralf Küppers, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros P. Vassilakopoulos, Michael Hummel, Richard Rosenquist, Frederik Damm

Blood (2016) 128 (23): 2666–2670.

https://doi.org/10.1182/blood-2016-03-704528

Published: 2016

Includes: Supplemental data

Journal Articles

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, MD, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, MD PhD, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, MD, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**

Blood (2016) 128 (22): 609.

https://doi.org/10.1182/blood.V128.22.609.609

Published: 2016

Journal Articles

Loss of PRDM11 promotes MYC-driven lymphomagenesis

Cathrine Kolster Fog, Fazila Asmar, Christophe Côme, Klaus Thorleif Jensen, Jens Vilstrup Johansen, Tony Bou Kheir, Linda Jacobsen, Carsten Friis, Alison Louw, Louise Rosgaard, Nina Friesgaard Øbro, Hanne Vibeke Marquart, Kristian Anthonsen, Arie Koen Braat, Maarten van Lohuizen, Elisabeth Ralfkiaer, Kirsten Grønbæk, Anders Henrik Lund

Blood (2015) 125 (8): 1272–1281.

https://doi.org/10.1182/blood-2014-03-560805

Published: 2015

Includes: Supplemental data

Journal Articles

Epigenetic Silencing of Mir-203 Contributes to IL2Rb Overexpression and Malignant Transformation in Cutaneous T-Cell Lymphoma

Ulrik Ralfkiaer, Martin Jansson, Katharina Kopp, Andreas Willerslev-Olsen, Fazila Asmar, Thorbjorn Krejsgaard, Peter de Nully Brown, Robert Gniadecki, Anders Woetman, Anders Lund, Niels Odum, Kirsten Groenbaek

Blood (2014) 124 (21): 3553.

https://doi.org/10.1182/blood.V124.21.3553.3553

Published: 2014

Journal Articles

DNA Methylation Profiling of Sorted Cells from Myelofibrosis Patients reveals Aberrant Epigenetic Regulation of Immune Pathways and identifies Early MPN Driver Genes

Hans Carl Hasselbalch, MD PhD, Helene Myrtue Nielsen, Cand.scient, Fazila Asmar, MD, Christen Lykkegaard Andersen, MD, Lasse Sommer Kristensen, PhD, Kruse A Torben, Mads Thomassen, PhD, Thomas Stauffer Larsen, Vibe Skov, PhD, Caroline Riley, MD, Lise Lotte Hansen, PhD, Morten K. Jensen, MD, Ole Weis Bjerrum, MD, Vasu Punj, Kirsten Grønbæk, MD DMSc

Blood (2014) 124 (21): 4576.

https://doi.org/10.1182/blood.V124.21.4576.4576

Published: 2014

Journal Articles

miRNA-130a regulates C/EBP-ε expression during granulopoiesis

Maria T. Larsen, Mattias Häger, Andreas Glenthøj, Fazila Asmar, Stine N. Clemmensen, Helena Mora-Jensen, Niels Borregaard, Jack B. Cowland

Blood (2014) 123 (7): 1079–1089.

https://doi.org/10.1182/blood-2013-08-523233

Published: 2014

Includes: Supplemental data

Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc

Blood (2013) 122 (21): 83.

https://doi.org/10.1182/blood.V122.21.83.83

Published: 2013

Journal Articles

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

Christoffer Hother, MD, Fazila Asmar, MD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD, Ditte Reker, Ulrik Ralfkiaer, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 296.

https://doi.org/10.1182/blood.V120.21.296.296

Published: 2012

Journal Articles

TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes

Fazila Asmar, Jesper Christensen, Jens V Johansen, Anders Blåbjerg, Anja Pedersen, Christoffer Hother, Ulrik Ralfkiaer, Kristian Helin, Kirsten Grønbæk

Blood (2011) 118 (21): 1364.

https://doi.org/10.1182/blood.V118.21.1364.1364

Published: 2011

Journal Articles

PRDM11 Is a Novel Putative Tumor Suppressor In Aggressive B Cell Lymphoma

Fazila Asmar, MD, Cathrine Kolster Fog, PhD, M.Sc., Klaus Jensen, PhD, DVM, Linda Jacobsen, PhD, M.Sc., Elisabeth Ralfkiær, Dr.Med, MD, Christian H. Geisler, PhD, MD, Kirsten Gr∅nbæk, Dr.Med., MD, Anders Lund, PhD, M.sc.

Blood (2010) 116 (21): 1002.

https://doi.org/10.1182/blood.V116.21.1002.1002

Published: 2010

NARROW

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Loss of PRDM11 promotes MYC-driven lymphomagenesis

Epigenetic Silencing of Mir-203 Contributes to IL2Rb Overexpression and Malignant Transformation in Cutaneous T-Cell Lymphoma

DNA Methylation Profiling of Sorted Cells from Myelofibrosis Patients reveals Aberrant Epigenetic Regulation of Immune Pathways and identifies Early MPN Driver Genes

miRNA-130a regulates C/EBP-ε expression during granulopoiesis

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes

PRDM11 Is a Novel Putative Tumor Suppressor In Aggressive B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only